A combination of a ready-to-use SMN protein and an experimental treatment targeting the SMN2 gene, which works in a similar way to Spinraza (nusinersen), eased abnormalities in motor neurons derived ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback